Medical Research
(H30)
990 on File
NORTHERN MICHIGAN HEMATOLOGY AND ONCOLGY
Financial strength (30%)
53/100
Reliability (20%)
50/100
Effectiveness (25%)
41/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$157
Total Revenue
$20
Total Expenses
$181K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
0.0%
Fundraising Efficiency
N/A
Operating Reserve
108886.80x
Liability-to-Asset
5.4%
Revenue Diversification
100.0%
Compared with Peers
FY 2024
Compared with 782 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 78.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
100.0% | 12.2% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
108886.8 mo | 38.9 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
5.4% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 100.0% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
1021.4% | -0.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
87.3% | 15.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $157 | $20 | $181K | 0.0% | 0 |
| 2023 | $14 | $0 | $181K | — | 0 |
| 2022 | $21 | $0 | $181K | — | 0 |
| 2021 | $3 | $0 | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.